Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BSX

Boston Scientific (BSX)

Boston Scientific Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:BSX
DateTimeSourceHeadlineSymbolCompany
04/08/202412:00AMPR Newswire (US)Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software ModuleNYSE:BSXBoston Scientific Corporation
04/01/20248:00AMPR Newswire (US)Boston Scientific Announces Conference Call Discussing First Quarter 2024 ResultsNYSE:BSXBoston Scientific Corporation
03/01/20246:55AMPR Newswire (US)Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated BalloonNYSE:BSXBoston Scientific Corporation
02/27/20244:15PMPR Newswire (US)Boston Scientific Announces Completion of €2.0 Billion Offering of Senior NotesNYSE:BSXBoston Scientific Corporation
02/22/20249:27PMPR Newswire (US)Boston Scientific Announces Pricing of €2.0 Billion of Senior NotesNYSE:BSXBoston Scientific Corporation
02/05/20248:00AMPR Newswire (US)Boston Scientific to Participate in TD Cowen's 44th Annual Health Care ConferenceNYSE:BSXBoston Scientific Corporation
01/31/20246:30AMPR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NYSE:BSXBoston Scientific Corporation
01/31/20246:29AMIH Market NewsU.S. Futures Waver Ahead of Fed Decision Amid Mixed Corporate Earnings; Oil Prices SlideNYSE:BSXBoston Scientific Corporation
01/31/20246:25AMPR Newswire (US)Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation SystemNYSE:BSXBoston Scientific Corporation
01/08/20244:55PMPR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NYSE:BSXBoston Scientific Corporation
01/08/202411:36AMDow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNYSE:BSXBoston Scientific Corporation
01/08/20247:41AMDow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNYSE:BSXBoston Scientific Corporation
01/08/20247:00AMBusiness WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNYSE:BSXBoston Scientific Corporation
01/08/20247:00AMPR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NYSE:BSXBoston Scientific Corporation
01/05/20248:00AMPR Newswire (US)Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
12/28/20234:00PMPR Newswire (US)Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial FibrillationNYSE:BSXBoston Scientific Corporation
11/17/20239:00AMPR Newswire (US)Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.NYSE:BSXBoston Scientific Corporation
11/01/20238:00AMPR Newswire (US)Boston Scientific to Participate in Stifel's 2023 Healthcare ConferenceNYSE:BSXBoston Scientific Corporation
10/26/20236:30AMPR Newswire (US)BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023NYSE:BSXBoston Scientific Corporation
10/25/20235:18PMAllPennyStocks.comMicrocap Offers Unique Opportunity for Investors In $10 Billion SCI IndustryNYSE:BSXBoston Scientific Corporation
10/25/20233:32PMDow Jones NewsBoston Scientific Gets Positive Results for Heart-Failure DeviceNYSE:BSXBoston Scientific Corporation
10/25/20232:29PMPR Newswire (US)Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE TrialNYSE:BSXBoston Scientific Corporation
10/24/20233:18PMPR Newswire (US)REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary EmbolismNYSE:BSXBoston Scientific Corporation
10/11/202311:19AMDow Jones NewsBoston Scientific Down Over 6%, on Pace for Largest Percent Decrease Since May 2022 -- Data TalkNYSE:BSXBoston Scientific Corporation
10/02/20236:30AMPR Newswire (US)Boston Scientific Announces Conference Call Discussing Third Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
09/21/20236:45AMPR Newswire (US)CVS Health appoints Michael F. Mahoney to its Board of DirectorsNYSE:BSXBoston Scientific Corporation
09/19/20237:45AMDow Jones NewsBoston Scientific to Buy Relievant Medsystems for Initial $800 MillionNYSE:BSXBoston Scientific Corporation
09/19/20237:00AMPR Newswire (US)Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.NYSE:BSXBoston Scientific Corporation
09/06/20234:47PMDow Jones NewsBoston Scientific's Watchman Flx Pro Device Gets FDA ApprovalNYSE:BSXBoston Scientific Corporation
09/06/20234:00PMPR Newswire (US)Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure DeviceNYSE:BSXBoston Scientific Corporation
 Showing the most relevant articles for your search:NYSE:BSX